Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Genetic double-agents unmasked

26.10.2004


Babraham Institute and Cancer Research UK scientists have discovered that certain enzymes with a key activity in the immune system may be important in stem-cell development, but may also work against us by contributing to the occurrence of cancer.

The usual targets

A family of enzymes known as DNA deaminases beneficially mutates the genetic code of antibodies to improve their ability to recognise foreign bodies. The usual target for the enzymes’ activity is cytosine (C), one of the four building blocks of DNA, however this research has shown that the enzymes can also target another DNA component: methylcytosine (cytosine carrying a methyl chemical group).



Double-agents

The discovery may help to explain how methylcytosine is removed from DNA in naturally-occurring situations, such as stem-cell development, but it also suggests a possible mechanism for the mutations that occur in up to one third of hereditary diseases and many cancers. Hence DNA deaminases may be acting as ‘double-agents’.

Dr Wolf Reik, Head of Developmental Genetics and Imprinting at the Babraham Institute, explains: “The removal of methyl groups from DNA is a sought-after activity implicated in the ability of stem-cells to develop into any other cell in the body, but it is uncertain how this demethylation could occur. The activity we have found in DNA deaminases provides a potential explanation of the mechanism. However, incorrect repair of the DNA during this process may result in mutations that could increase a person’s chance of developing cancer.”

Interpreting the code

Methylcytosine is an example of an ‘epigenetic’ mark – a heritable modification of DNA that affects the way in which a gene is read, without changing the DNA code itself. Epigenetics is an important area of research because epigenetic marks are essential for normal development and they can become misdirected in the cell, leading to cancer and other human diseases.

The discovery of the actions of these enzymes, described in a paper published in the Journal of Biological Chemistry, was made by Dr Hugh Morgan and colleagues, working with Dr Wolf Reik at the Babraham Institute, and in collaboration with Dr Svend Peterson-Mahrt at Cancer Research UK.

Emma Southern | alfa
Further information:
http://www.babraham.ac.uk

More articles from Life Sciences:

nachricht New way to look at cell membranes could change the way we study disease
19.11.2018 | University of Oxford

nachricht Controlling organ growth with light
19.11.2018 | European Molecular Biology Laboratory

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: UNH scientists help provide first-ever views of elusive energy explosion

Researchers at the University of New Hampshire have captured a difficult-to-view singular event involving "magnetic reconnection"--the process by which sparse particles and energy around Earth collide producing a quick but mighty explosion--in the Earth's magnetotail, the magnetic environment that trails behind the planet.

Magnetic reconnection has remained a bit of a mystery to scientists. They know it exists and have documented the effects that the energy explosions can...

Im Focus: A Chip with Blood Vessels

Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.

Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...

Im Focus: A Leap Into Quantum Technology

Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.

In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...

Im Focus: Research icebreaker Polarstern begins the Antarctic season

What does it look like below the ice shelf of the calved massive iceberg A68?

On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.

Im Focus: Penn engineers develop ultrathin, ultralight 'nanocardboard'

When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure

Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Optical Coherence Tomography: German-Japanese Research Alliance hosted Medical Imaging Conference

19.11.2018 | Event News

“3rd Conference on Laser Polishing – LaP 2018” Attracts International Experts and Users

09.11.2018 | Event News

On the brain’s ability to find the right direction

06.11.2018 | Event News

 
Latest News

New materials: Growing polymer pelts

19.11.2018 | Materials Sciences

Earthquake researchers finalists for supercomputing prize

19.11.2018 | Information Technology

Controlling organ growth with light

19.11.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>